Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
| Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
|---|---|---|
| Current Price | $7.78 | $4.93 |
| Change | 0.14 (1.90%) | 0.10 (2.07%) |
| Market Cap | $0.60B | $0.22B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -2.89 | -8.50 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $17.00 | $17.78 |
| 52-Week Low | $4.92 | $3.86 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.07 | $-0.67 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| REPL | -28.14% | -34.39% | 21.11% | -30.52% | -48.71% | -48.71% |
| YMAB | -1.40% | -20.36% | -67.48% | -84.78% | -79.46% | -79.46% |